Skip to main content
Prognostic and predictive blood-based biomarkers for pancreatic cancer

Prognostic and predictive blood-based biomarkers for pancreatic cancer

Value Proposition Pancreatic cancer is among the deadliest types of cancer, with only 8.2% of patients surviving five years after diagnosis. Therapeutics that inhibit either VEGF signaling pathways or mitogenic signaling through the epidermal growth…

Read More

Rapid immunoassay to detect anti-EGFRviii levels to evaluate vaccine efficacy

Rapid immunoassay to detect anti-EGFRviii levels to evaluate vaccine efficacy

Value Proposition Tumor-specific molecules offer the possibility of targeted cancer therapy using monoclonal antibodies (mAbs) specifically directed against the tumor-specific molecule. However, it has proven difficult to identify tumor-specific molecules. Overexpression of EGFR in human…

Read More

Components of the Wnt-Beta-catenin paracrine signaling pathway as predictive biomarkers for cancer immunotherapy

Components of the Wnt-Beta-catenin paracrine signaling pathway as predictive biomarkers for cancer immunotherapy

Value Proposition Immunotherapy is a promising approach for the treatment of many cancers. However, despite early success, majority of patients with advanced cancer fail to respond or become resistant. In even the most immunogenic cancer…

Read More

Endoscopic optical assessment of tissue histology

Endoscopic optical assessment of tissue histology

Value Proposition Endoscopy is an extremely important and prevalent procedure for the diagnosis of a variety of disorders affecting the esophageal and gastrointestinal tracts such as colorectal cancer, adenoma, inflammatory bowel disease, and intestinal metaplasia.…

Read More

Black blood delayed enhancement magnetic resonance imaging

Black blood delayed enhancement magnetic resonance imaging

Technnology Duke University is seeking a corporate partners to commercialize a method of improved detection of infarcted heart tissue. The technology provides a dark blood delayed enhancement technique that improves the visualization of subendocardial infarcts…

Read More

A diagnostic test for differentiating follicular thyroid adenoma for follicular thyroid carcinoma

A diagnostic test for differentiating follicular thyroid adenoma for follicular thyroid carcinoma

Duke University is seeking a company interested in commercializing a novel method to distinguish follicular thyroid adenoma (FTA) from follicular thyroid carcinoma (FTC). Global estimates of thyroid cancer incidence for 2006 indicate half a million…

Read More

Mast cell targeting to predict and prevent virus-induced vascular leakage

Mast cell targeting to predict and prevent virus-induced vascular leakage

Value Proposition Dengue is a mosquito spread virus that affects millions of people worldwide. According to the World Health Organization, there are approximately 390 million dengue virus infections each year, and it is the leading…

Read More

Molecular classifiers of bacterial infection

Molecular classifiers of bacterial infection

Disclosed herein are biomarkers useful for identifying and/or classifying bacterial infections in a subject.

Read More

Antibodies for the detection of Ebola virus infection

Antibodies for the detection of Ebola virus infection

Value Proposition Ebola Virus Disease (EVD) is a severe, often fatal illness in humans caused by one of five different Ebola viruses. The virus is transmitted to people from wild animals and spreads in the…

Read More

Biomarkers to measure patient platelet functional status on aspirin and predict cardiovascular events

Biomarkers to measure patient platelet functional status on aspirin and predict cardiovascular events

Value Proposition Aspirin is the most commonly prescribed anti-platelet medication for prevention of acute coronary syndrome (ACS), which continues to be the leading cause of morbidity and mortality in the U.S. Aspirin has long been…

Read More

Diagnostic and treatment for chronic and acute phase myeloid leukemia

Diagnostic and treatment for chronic and acute phase myeloid leukemia

Value Proposition While cancer therapies have increased survival for many tumor types, the reality is that 50-60% of cancer patients will die from the disease. This highlights a need for the continued search for targeted…

Read More

SUMO as a marker of cancer development and target for cancer therapy

SUMO as a marker of cancer development and target for cancer therapy

Value Proposition Cancer therapy remains challenging, and the production of new inhibitor therapies is stinted by the need for clear successful targets that will block tumor cell proliferation. Small ubiquitin-like modifier (SUMO) proteins and the…

Read More

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us